Patient persistence with first-line antiglaucomatous monotherapy
Alfonso Arias1, Konrad Schargel2, Fernando Ussa3, Maria I Canut4, Amelia y Belén Robles4, Belén Martí Sánchez51Ophthalmology Department, Fundación Hospital Alcorcón, Madrid; 2Ophthalmology Department, Hospital...
Guardado en:
Autores principales: | Alfonso Arias, Konrad Schargel, Fernando Ussa, et al |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2010
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ac707c60abd644539e59ff9516e4938d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Daily costs of prostaglandin analogues as monotherapy or in fixed combinations with timolol, in Denmark, Finland, Germany and Sweden
por: Anders Bergström, et al.
Publicado: (2009) -
Switching patients from preserved prostaglandin-analog monotherapy to preservative-free tafluprost
por: Hommer A, et al.
Publicado: (2011) -
Visual outcomes of age-related macular degeneration patients undergoing intravitreal ranibizumab monotherapy in an urban population
por: Basheer K, et al.
Publicado: (2015) -
Retinal nerve fiber layer thickness in recovered and persistent amblyopia
por: Atsushi Miki, et al.
Publicado: (2010) -
Visual outcomes of age-related macular degeneration patients undergoing intravitreal ranibizumab monotherapy in an urban population: letter to the editor
por: Stewart MW
Publicado: (2015)